Company · Mississauga, Ontario, Canada
Glaxosmithkline Inc
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 305
- 93 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 4
- 0 active
- Notices of Compliance
- 684
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| ADVAIR | 02245126 | Marketed | |
| ADVAIR | 02245127 | Marketed | |
| ADVAIR 100 DISKUS | 02240835 | Marketed | |
| ADVAIR 250 DISKUS | 02240836 | Marketed | |
| ADVAIR 500 DISKUS | 02240837 | Marketed | |
| ANORO ELLIPTA | 02418401 | Marketed | |
| AREXVY | 02540207 | Marketed | |
| ARNUITY ELLIPTA | 02446561 | Marketed | |
| ARNUITY ELLIPTA | 02446588 | Marketed | |
| AVAMYS | 02298589 | Marketed | |
| AVODART | 02247813 | Marketed | |
| BENLYSTA | 02370050 | Marketed | |
| BENLYSTA | 02370069 | Marketed | |
| BENLYSTA | 02470489 | Marketed | |
| BEXSERO | 02417030 | Marketed | |
| BLENREP | 02559617 | Marketed | |
| BLENREP | 02559625 | Marketed | |
| BOOSTRIX | 02247600 | Marketed | |
| BOOSTRIX-POLIO | 02312557 | Marketed | |
| BREO ELLIPTA | 02408872 | Marketed | |
| BREO ELLIPTA | 02444186 | Marketed | |
| CERVARIX | 02342227 | Marketed | |
| CLAVULIN 125 F ORAL SUS | 01916882 | Marketed | |
| CLAVULIN 200 | 02238831 | Marketed | |
| CLAVULIN 250 F ORAL SUS | 01916874 | Marketed | |
| CLAVULIN 400 | 02238830 | Marketed | |
| CLINDOXYL ADV GEL | 02382822 | Marketed | |
| ENGERIX-B | 02487020 | Marketed | |
| ENGERIX-B | 02487039 | Marketed | |
| EXDENSUR | 02568926 | Marketed | |
| EXDENSUR | 02568934 | Marketed | |
| FLOLAN | 02230845 | Marketed | |
| FLOLAN | 02230848 | Marketed | |
| FLOVENT DISKUS | 02237245 | Marketed | |
| FLOVENT DISKUS | 02237246 | Marketed | |
| FLOVENT DISKUS | 02237247 | Marketed | |
| FLOVENT HFA | 02244291 | Marketed | |
| FLOVENT HFA | 02244292 | Marketed | |
| FLOVENT HFA | 02244293 | Marketed | |
| HAVRIX 1440 | 02187078 | Marketed | |
| HAVRIX 720 JUNIOR | 02231056 | Marketed | |
| IMITREX | 02212188 | Marketed | |
| IMITREX | 02230418 | Marketed | |
| IMITREX | 02230420 | Marketed | |
| IMITREX DF - TAB 100MG | 02212161 | Marketed | |
| INCRUSE ELLIPTA | 02423596 | Marketed | |
| INFANRIX HEXA | 02253852 | Marketed | |
| INFANRIX-IPV/HIB | 02257122 | Marketed | |
| JALYN | 02372010 | Marketed | |
| JEMPERLI | 02523434 | Marketed | |
| LAMICTAL | 02142112 | Marketed | |
| LAMICTAL | 02142104 | Marketed | |
| LAMICTAL | 02142082 | Marketed | |
| LAMICTAL | 02240115 | Marketed | |
| LAMICTAL | 02243803 | Marketed | |
| MALARONE | 02238151 | Marketed | |
| MALARONE PEDIATRIC | 02264935 | Marketed | |
| MENVEO | 02347393 | Marketed | |
| MENVEO | 02563029 | Marketed | |
| MEPRON | 02217422 | Marketed | |
| NUCALA | 02492989 | Marketed | |
| NUCALA | 02492997 | Marketed | |
| NUCALA | 02530821 | Marketed | |
| OJJAARA | 02552965 | Marketed | |
| OJJAARA | 02552973 | Marketed | |
| OJJAARA | 02552981 | Marketed | |
| PARNATE | 01919598 | Marketed | |
| PAXIL CR | 02248503 | Marketed | |
| PAXIL CR | 02248504 | Marketed | |
| PAXIL TAB 20MG | 01940481 | Marketed | |
| PH 12 STERILE DILUENT FOR FLOLAN | 02443651 | Marketed | |
| PRIORIX | 02239208 | Marketed | |
| PRIORIX-TETRA | 02297884 | Marketed | |
| RELENZA | 02240863 | Marketed | |
| ROTARIX | 02300591 | Marketed | |
| SEREVENT DISKUS (50MCG/DOSE) | 02231129 | Marketed | |
| SHINGRIX | 02468425 | Marketed | |
| TRELEGY ELLIPTA | 02474522 | Marketed | |
| TRELEGY ELLIPTA | 02515776 | Marketed | |
| TWINRIX | 02230578 | Marketed | |
| TWINRIX JUNIOR | 02237548 | Marketed | |
| VALTREX | 02219492 | Marketed | |
| VALTREX | 02246559 | Marketed | |
| VARILRIX | 02241047 | Marketed | |
| VENTOLIN DISKUS | 02243115 | Marketed | |
| VENTOLIN HFA | 02241497 | Marketed | |
| VENTOLIN I.V. INFUSION SOLUTION 5.0MG SALBUTAMOL IN 5ML (1000MCG/ML) | 02213451 | Marketed | |
| VENTOLIN RESPIRATOR SOLUTION | 02213486 | Marketed | |
| VOLIBRIS | 02307065 | Marketed | |
| VOLIBRIS | 02307073 | Marketed | |
| ZEJULA | 02530031 | Marketed | |
| SHINGRIX | 02570270 | Approved | |
| ZEJULA | 02489783 | Dormant | |
| ACNE AID SOAP 6.3% | 00187607 | Cancelled Post Market | |
| AGENERASE | 02243541 | Cancelled Post Market | |
| AGENERASE | 02243542 | Cancelled Post Market | |
| AGENERASE | 02243543 | Cancelled Post Market | |
| ALTARGO | 02307502 | Cancelled Pre Market | |
| AMERGE | 02237820 | Cancelled Post Market | |
| AMERGE | 02237821 | Cancelled Post Market | |
| AVANDAMET | 02247085 | Cancelled Post Market | |
| AVANDAMET | 02247086 | Cancelled Post Market | |
| AVANDAMET | 02247087 | Cancelled Post Market | |
| AVANDAMET | 02248440 | Cancelled Post Market | |
| AVANDAMET | 02248441 | Cancelled Post Market | |
| AVANDARYL | 02258781 | Cancelled Post Market | |
| AVANDARYL | 02258803 | Cancelled Post Market | |
| AVANDARYL | 02258811 | Cancelled Post Market | |
| AVANDIA | 02241112 | Cancelled Post Market | |
| AVANDIA | 02241113 | Cancelled Post Market | |
| AVANDIA | 02241114 | Cancelled Post Market | |
| BACTROBAN NASAL OINTMENT | 02236776 | Cancelled Pre Market | |
| BENLYSTA | 02470470 | Cancelled Pre Market | |
| BENOXYL | 00236063 | Cancelled Post Market | |
| BENOXYL | 00187585 | Cancelled Post Market | |
| BENOXYL | 00370568 | Cancelled Post Market | |
| BEXXAR THERAPY | 02270471 | Cancelled Post Market | |
| BURO SOL ANTISEPTIC POWDER | 00579947 | Cancelled Post Market | |
| BURO-SOL OTIC SOLUTION | 00674222 | Cancelled Post Market | |
| CEFIZOX | 01919490 | Cancelled Post Market | |
| CEFIZOX | 01919504 | Cancelled Post Market | |
| CEFTIN - PWR 250MG/SACHET | 02212293 | Cancelled Post Market | |
| CEFTIN - TAB 250MG | 02212277 | Cancelled Post Market | |
| CEFTIN - TAB 500MG | 02212285 | Cancelled Post Market | |
| CEPTAZ INJECTION - PWS IM IV 1G/VIAL | 02215012 | Cancelled Post Market | |
| CEPTAZ INJECTION - PWS IV 10GM/VIAL | 02213737 | Cancelled Post Market | |
| CEPTAZ INJECTION - PWS IV 2GM/VIAL | 02215020 | Cancelled Post Market | |
| CICATRIN POWDER | 00666173 | Cancelled Post Market | |
| CLAVULIN 250 TAB | 01916866 | Cancelled Post Market | |
| CLAVULIN 500 F TAB | 01916858 | Cancelled Post Market | |
| CLAVULIN 875 | 02238829 | Cancelled Post Market | |
| CLINDASOL | 02242970 | Cancelled Post Market | |
| CLINDETS | 02243050 | Cancelled Post Market | |
| CLINDOXYL GEL | 02243158 | Cancelled Post Market | |
| COACTIFED | 00068608 | Cancelled Post Market | |
| COACTIFED | 00068756 | Cancelled Post Market | |
| COACTIFED | 00068594 | Cancelled Post Market | |
| COREG (CARVEDILOL) TABLETS, 12.5MG | 02229652 | Cancelled Post Market | |
| COREG (CARVEDILOL) TABLETS, 25MG | 02229653 | Cancelled Post Market | |
| COREG (CARVEDILOL) TABLETS, 3.125 MG | 02229650 | Cancelled Post Market | |
| COREG (CARVEDILOL) TABLETS, 6.25MG | 02229651 | Cancelled Post Market | |
| CORTISPORIN | 00666246 | Cancelled Post Market | |
| CORTISPORIN | 00701904 | Cancelled Post Market | |
| CORTISPORIN | 01912828 | Cancelled Post Market | |
| CORTISPORIN | 02025736 | Cancelled Post Market | |
| CUTIVATE | 02089912 | Cancelled Post Market | |
| CYCLOCORT | 02192268 | Cancelled Post Market | |
| CYCLOCORT | 02192276 | Cancelled Post Market | |
| CYCLOCORT | 02192284 | Cancelled Post Market | |
| DIGIBIND | 02146967 | Cancelled Post Market | |
| DOAK OIL | 00579955 | Cancelled Post Market | |
| DOAK OIL FORTE | 00579971 | Cancelled Post Market | |
| DYRENIUM 100 | 01919571 | Cancelled Post Market | |
| DYRENIUM 50 | 01919563 | Cancelled Post Market | |
| EMO CORT CREAM 2.5% | 00595799 | Cancelled Post Market | |
| EMO CORT LOTION 2.5% | 00595802 | Cancelled Post Market | |
| EMO CORT SOL 2.5% USP | 00641154 | Cancelled Post Market | |
| EMPRACET-30 | 00666130 | Cancelled Post Market | |
| EMPRACET-60 | 00666149 | Cancelled Post Market | |
| ENGERIX-B | 01919431 | Cancelled Post Market | |
| ENGERIX-B | 02296454 | Cancelled Post Market | |
| EPERZAN | 02443635 | Cancelled Pre Market | |
| EPERZAN | 02443643 | Cancelled Pre Market | |
| ERYSOL | 02034506 | Cancelled Post Market | |
| EXOSURF NEONATAL | 01927183 | Cancelled Post Market | |
| EXOSURF NEONATAL | 01927175 | Cancelled Post Market | |
| FLONASE - AEM-SUS NAS 50MCG/MD | 02213672 | Cancelled Post Market | |
| FLOVENT DISKUS | 02237244 | Cancelled Post Market | |
| FLOVENT INHALERS - AEM INH-ORL 125MCG/AEM | 02213605 | Cancelled Post Market | |
| FLOVENT INHALERS - AEM INH-ORL 250MCG/AEM | 02213613 | Cancelled Post Market | |
| FLOVENT INHALERS - AEM INH-ORL 25MCG/AEM | 02213583 | Cancelled Post Market | |
| FLOVENT INHALERS - AEM INH-ORL 50MCG/AEM | 02213591 | Cancelled Post Market | |
| FORTAZ | 02212218 | Cancelled Post Market | |
| FORTAZ | 02212226 | Cancelled Post Market | |
| FORTAZ | 02212234 | Cancelled Post Market | |
| HAVRIX - 720UNIT/ML SUS | 02108216 | Cancelled Post Market | |
| HEPTOVIR | 02239193 | Cancelled Post Market | |
| HEPTOVIR | 02239194 | Cancelled Post Market | |
| HIBERIX | 02239200 | Cancelled Post Market | |
| IMITREX DF | 02212153 | Cancelled Post Market | |
| IMITREX DF - TAB 25MG | 02239738 | Cancelled Post Market | |
| INFANRIX-IPV | 02241284 | Cancelled Post Market | |
| KEMADRIN ELX | 00004405 | Cancelled Post Market | |
| KEMADRIN TAB 5MG | 00004758 | Cancelled Post Market | |
| LYMERIX | 02239195 | Cancelled Post Market | |
| MENCEVAX AC PWS 500MCG/VIAL | 01962922 | Cancelled Post Market | |
| MENCEVAX AC PWS 50MCG/VIAL | 01962914 | Cancelled Post Market | |
| MENCEVAX AC PWS INJ 2500MCG/VIAL | 01962930 | Cancelled Post Market | |
| MENJUGATE | 02243820 | Cancelled Post Market | |
| MENJUGATE LIQUID | 02440709 | Cancelled Post Market | |
| MESASAL | 01914030 | Cancelled Post Market | |
| MINOCIN | 02173506 | Cancelled Post Market | |
| MINOCIN | 02173514 | Cancelled Post Market | |
| NEOSPORIN ANTIBIOTIC CREAM | 00666203 | Cancelled Post Market | |
| NEOSPORIN EYE-EAR SOLUTION | 00694371 | Cancelled Post Market | |
| NEOSPORIN IRRIGATING SOLUTION | 00666157 | Cancelled Post Market | |
| NEOSPORIN OINTMENT | 00666122 | Cancelled Post Market | |
| NEOSPORIN OPHTHALMIC OINTMENT | 00694398 | Cancelled Post Market | |
| NERISALIC OILY CREAM | 02028719 | Cancelled Post Market | |
| NERISONE CREAM | 00587826 | Cancelled Post Market | |
| NERISONE OILY CREAM | 00587818 | Cancelled Post Market | |
| NERISONE OINTMENT | 00587834 | Cancelled Post Market | |
| NUCALA | 02449781 | Cancelled Post Market | |
| OILATUM | 02034670 | Cancelled Post Market | |
| PANOXYL 10 BAR 10% | 00527661 | Cancelled Post Market | |
| PANOXYL 10 GEL | 00263699 | Cancelled Post Market | |
| PANOXYL 20 GEL | 00373036 | Cancelled Post Market | |
| PANOXYL 5 BAR | 00483184 | Cancelled Post Market | |
| PANOXYL 5 GEL | 00263702 | Cancelled Post Market | |
| PANOXYL AQUAGEL 2.5% | 02214830 | Cancelled Post Market | |
| PANOXYL AQUAGEL 5% | 02214849 | Cancelled Post Market | |
| PANOXYL CLEAR ACNE CLEANSING GEL | 00754927 | Cancelled Post Market | |
| PANOXYL CREAMY WASH 4% | 02188708 | Cancelled Post Market | |
| PANOXYL WASH 5% - LOT | 02214857 | Cancelled Post Market | |
| PAXIL CR | 02267128 | Cancelled Pre Market | |
| PAXIL TAB 10MG | 02027887 | Cancelled Post Market | |
| PAXIL TAB 30MG | 01940473 | Cancelled Post Market | |
| POLYTAR | 00249866 | Cancelled Post Market | |
| POLYTAR AF SHAMPOO | 01981021 | Cancelled Post Market | |
| POLYTAR MILD | 00419133 | Cancelled Post Market | |
| PREVEX B | 00804541 | Cancelled Post Market | |
| PROLOPRIM 200 TAB 200MG | 00677590 | Cancelled Post Market | |
| PROLOPRIM TAB 100MG | 00675229 | Cancelled Post Market | |
| REJUVA MOISTURIZING DAY CREAM SPF 30 | 02237874 | Cancelled Post Market | |
| REJUVA-A | 02192640 | Cancelled Post Market | |
| RELAFEN TABLETS 500MG | 02083531 | Cancelled Post Market | |
| RELAFEN TABLETS 750MG | 02083558 | Cancelled Post Market | |
| REQUIP | 02232565 | Cancelled Post Market | |
| REQUIP | 02232567 | Cancelled Post Market | |
| REQUIP | 02232568 | Cancelled Post Market | |
| REQUIP | 02232569 | Cancelled Post Market | |
| RETISOL-A | 02008726 | Cancelled Post Market | |
| RETISOL-A | 02008696 | Cancelled Post Market | |
| RETISOL-A | 02008688 | Cancelled Post Market | |
| RETISOL-A | 02008718 | Cancelled Post Market | |
| ROSASOL | 02242919 | Cancelled Post Market | |
| SARNA HC | 00856711 | Cancelled Post Market | |
| SARNA P | 00874825 | Cancelled Post Market | |
| SEPTRA | 00270636 | Cancelled Post Market | |
| SEPTRA DS TABLETS | 00368040 | Cancelled Post Market | |
| SEREVENT (25MCG/ACTUATION) | 02211742 | Cancelled Post Market | |
| SEREVENT DISKHALER DISK (50MCG/DOSE) | 02214261 | Cancelled Post Market | |
| SOLAGÉ | 02243257 | Cancelled Post Market | |
| SOLUGEL | 01975382 | Cancelled Post Market | |
| SOLUGEL | 02019825 | Cancelled Post Market | |
| SOTROVIMAB FOR INJECTION | 02518341 | Authorization By Interim Order Revoked | |
| STELABID FORTE | 01918281 | Cancelled Post Market | |
| STELABID NO 1 | 01918265 | Cancelled Post Market | |
| STELABID NO 2 | 01918273 | Cancelled Post Market | |
| STERILE DILUENT FOR FLOLAN INJECTION | 02230857 | Cancelled Post Market | |
| STIEPROX SHAMPOO | 02247228 | Cancelled Post Market | |
| STIEVA-A | 00518182 | Cancelled Post Market | |
| STIEVA-A | 00578576 | Cancelled Post Market | |
| STIEVA-A | 00657204 | Cancelled Post Market | |
| STIEVA-A CREAM | 00662348 | Cancelled Post Market | |
| STIEVA-A GEL | 00587966 | Cancelled Post Market | |
| STIEVA-A GEL | 00641863 | Cancelled Post Market | |
| STIEVA-A SOLUTION | 00578568 | Cancelled Post Market | |
| STIEVAMYCIN FORTE | 01945262 | Cancelled Post Market | |
| STIEVAMYCIN MILD | 02015994 | Cancelled Post Market | |
| STIEVAMYCIN REGULAR | 01905112 | Cancelled Post Market | |
| SYNFLORIX | 02320541 | Cancelled Post Market | |
| TAGAMET 300 | 01916815 | Cancelled Post Market | |
| TAGAMET 400 | 01916785 | Cancelled Post Market | |
| TAGAMET 600 | 01916777 | Cancelled Post Market | |
| TAGAMET LIQUID 60MG/ML | 01916750 | Cancelled Post Market | |
| TERSA TAR | 00632309 | Cancelled Post Market | |
| TERSA-TAR MILD SHP 1% | 00632295 | Cancelled Post Market | |
| TERSASEPTIC | 00632317 | Cancelled Post Market | |
| TIMENTIN | 01916939 | Cancelled Post Market | |
| TIMENTIN | 02247880 | Cancelled Post Market | |
| TOCTINO | 02337630 | Cancelled Post Market | |
| TOCTINO | 02337649 | Cancelled Post Market | |
| TYPHERIX | 02242727 | Cancelled Post Market | |
| UREMOL HC | 00503134 | Cancelled Post Market | |
| UREMOL HC | 00560022 | Cancelled Post Market | |
| VENTODISK 200MCG | 02214997 | Cancelled Post Market | |
| VENTODISK 400MCG | 02215004 | Cancelled Post Market | |
| VENTOLIN I.M. INJECTION 0.5MG SALBUTAMOL IN 1 ML (500MCG/ML) | 02213443 | Cancelled Post Market | |
| VENTOLIN I.V. BOLUS INJECTION 0.25MG SALBUTAMOL IN 5ML (50MCG/ML) | 02213435 | Cancelled Post Market | |
| VENTOLIN INHALER | 02213478 | Cancelled Post Market | |
| VENTOLIN NEBULES P.F. - 2.5MG/2.5ML | 02213419 | Cancelled Post Market | |
| VENTOLIN NEBULES P.F. - 5MG/2.5ML | 02213427 | Cancelled Post Market | |
| VENTOLIN NEBULES P.F.- 1.25MG/2.5ML | 02213400 | Cancelled Post Market | |
| VENTOLIN ORAL LIQUID | 02212390 | Cancelled Post Market | |
| VENTOLIN ROTACAPS | 02212315 | Cancelled Post Market | |
| VENTOLIN ROTACAPS | 02212323 | Cancelled Post Market | |
| VERDESO | 02348489 | Cancelled Post Market | |
| ZANTAC | 02212331 | Cancelled Post Market | |
| ZANTAC | 02212358 | Cancelled Post Market | |
| ZANTAC | 02212366 | Cancelled Post Market | |
| ZANTAC | 02212374 | Cancelled Post Market | |
| ZEASORB | 00237213 | Cancelled Post Market | |
| ZEASORB AF | 02029081 | Cancelled Post Market | |
| ZINACEF INJECTION - PWS IM IV 750MG/VIAL | 02213532 | Cancelled Post Market | |
| ZINACEF INJECTION - PWS IV 1.5GM/VIAL | 02213540 | Cancelled Post Market | |
| ZINACEF INJECTION - PWS IV 7.5GM/VIAL | 02213559 | Cancelled Post Market | |
| ZOVIRAX | 00605336 | Cancelled Post Market | |
| ZOVIRAX | 00886157 | Cancelled Post Market | |
| ZOVIRAX | 00899321 | Cancelled Post Market |
Showing 300 of 305 drug products. For the rest, search Health Canada’s database.
Medical device licences
Active licences first, newest first.
| Name | Licence | Status | First licensed |
|---|---|---|---|
| BEXXAR THERAPY DOSIMETRY SOFTWARE | 66737 | Cancelled · Class 2 | |
| ENDOTRACHEAL TUBE ADAPTERS | 9362 | Discontinued at renewal · Class 2 | |
| SPACER DEVICE | 9310 | Discontinued at renewal · Class 2 | |
| PYLORITEST | 3833 | Discontinued at renewal · Class 2 |
Notices of Compliance
Newest first.
- ZEJULAOctober 1, 2026 · NOC 38401 · Supplement to a New Drug Submission (SNDS)
- PARNATESeptember 29, 2026 · NOC 38396 · Supplement to a New Drug Submission (SNDS)
- BEXSEROSeptember 24, 2026 · NOC 38342 · Supplement to a New Drug Submission (SNDS)
- ADVAIRSeptember 24, 2026 · NOC 38353 · Supplement to a New Drug Submission (SNDS)
- ZEJULASeptember 17, 2026 · NOC 38312 · Supplement to a New Drug Submission (SNDS)
- PAXILSeptember 17, 2026 · NOC 38315 · Supplement to a New Drug Submission (SNDS)
- PAXIL CRAugust 24, 2026 · NOC 38164 · Supplement to a New Drug Submission (SNDS)
- AVODARTAugust 12, 2026 · NOC 38091 · Supplement to a New Drug Submission (SNDS)
- JALYNAugust 12, 2026 · NOC 38102 · Supplement to a New Drug Submission (SNDS)
- SHINGRIXJuly 23, 2026 · NOC 37969 · Supplement to a New Drug Submission (SNDS)
- VARILRIXJune 30, 2026 · NOC 37800 · Supplement to a New Drug Submission (SNDS)
- SHINGRIXJune 24, 2026 · NOC 37773 · Supplement to a New Drug Submission (SNDS)
- EXDENSURJune 15, 2026 · NOC 37709 · New Drug Submission (NDS)
- NUCALAJune 9, 2026 · NOC 37678 · Supplement to a New Drug Submission (SNDS)
- PRIORIX-TETRAJune 2, 2026 · NOC 37655 · Supplement to a New Drug Submission (SNDS)
- AREXVYMay 22, 2026 · NOC 37599 · Supplement to a New Drug Submission (SNDS)
- PRIORIXApril 27, 2026 · NOC 37415 · Supplement to a New Drug Submission (SNDS)
- PRIORIX-TETRAApril 27, 2026 · NOC 37416 · Supplement to a New Drug Submission (SNDS)
- ZEJULAApril 21, 2026 · NOC 37378 · Supplement to a New Drug Submission (SNDS)
- SYNFLORIXApril 7, 2026 · NOC 37273 · Supplement to a New Drug Submission (SNDS)
- SHINGRIXMarch 31, 2026 · NOC 37244 · Supplement to a New Drug Submission (SNDS)
- ADVAIR DISKUSMarch 20, 2026 · NOC 37143 · Supplement to a New Drug Submission (SNDS)
- OJJAARAMarch 20, 2026 · NOC 37151 · Supplement to a New Drug Submission (SNDS)
- MALARONE; MALARONE PEDIATRICMarch 17, 2026 · NOC 37122 · Supplement to a New Drug Submission (SNDS)
- BLENREPMarch 16, 2026 · NOC 37120 · Supplement to a New Drug Submission (SNDS)
- VALTREXMarch 13, 2026 · NOC 37098 · Supplement to a New Drug Submission (SNDS)
- MEPRONMarch 5, 2026 · NOC 37048 · Supplement to a New Drug Submission (SNDS)
- VARILRIXMarch 2, 2026 · NOC 37015 · Supplement to a New Drug Submission (SNDS)
- PRIORIX-TETRAMarch 2, 2026 · NOC 37021 · Supplement to a New Drug Submission (SNDS)
- PRIORIXFebruary 23, 2026 · NOC 36959 · Supplement to a New Drug Submission (SNDS)
- BENLYSTADecember 23, 2025 · NOC 36698 · Supplement to a New Drug Submission (SNDS)
- MENVEODecember 22, 2025 · NOC 36606 · Supplement to a New Drug Submission (SNDS)
- IMITREX; IMITREX DFDecember 9, 2025 · NOC 36499 · Supplement to a New Drug Submission (SNDS)
- BEXSERODecember 5, 2025 · NOC 36497 · Supplement to a New Drug Submission (SNDS)
- VOLIBRISDecember 2, 2025 · NOC 36465 · Supplement to a New Drug Submission (SNDS)
- MENVEONovember 21, 2025 · NOC 36545 · Supplement to a New Drug Submission (SNDS)
- SHINGRIXOctober 31, 2025 · NOC 36313 · Supplement to a New Drug Submission (SNDS)
- VENTOLIN DISKUSSeptember 19, 2025 · NOC 36040 · Supplement to a New Drug Submission (SNDS)
- VENTOLIN RESPIRATOR SOLUTIONAugust 29, 2025 · NOC 35927 · Supplement to a New Drug Submission (SNDS)
- VENTOLIN HFAAugust 22, 2025 · NOC 35887 · Supplement to a New Drug Submission (SNDS)
- BLENREPJuly 21, 2025 · NOC 35725 · New Drug Submission (NDS)
- AREXVYJuly 21, 2025 · NOC 35736 · Supplement to a New Drug Submission (SNDS)
- BLENREPJuly 18, 2025 · NOC 35724 · New Drug Submission (NDS)
- TWINRIXJuly 2, 2025 · NOC 35606 · Supplement to a New Drug Submission (SNDS)
- BOOSTRIX-POLIOJuly 2, 2025 · NOC 35620 · Supplement to a New Drug Submission (SNDS)
- BOOSTRIXJuly 2, 2025 · NOC 35621 · Supplement to a New Drug Submission (SNDS)
- INFANRIX-IPV/HIBJuly 2, 2025 · NOC 35622 · Supplement to a New Drug Submission (SNDS)
- INFANRIX HEXAJuly 2, 2025 · NOC 35623 · Supplement to a New Drug Submission (SNDS)
- HAVRIXJune 6, 2025 · NOC 35566 · Supplement to a New Drug Submission (SNDS)
- ENGERIX-BJune 6, 2025 · NOC 35567 · Supplement to a New Drug Submission (SNDS)
- ZEJULAMay 26, 2025 · NOC 35419 · Supplement to a New Drug Submission (SNDS)
- JEMPERLIApril 16, 2025 · NOC 35199 · Supplement to a New Drug Submission (SNDS)
- BENLYSTAApril 1, 2025 · NOC 35139 · Supplement to a New Drug Submission (SNDS)
- LAMICTALMarch 26, 2025 · NOC 35077 · Supplement to a New Drug Submission (SNDS)
- INFANRIX-IPV/HIBFebruary 27, 2025 · NOC 34932 · Supplement to a New Drug Submission (SNDS)
- VENTOLIN RESPIRATOR SOLUTIONFebruary 25, 2025 · NOC 34900 · Supplement to a New Drug Submission (SNDS)
- ADVAIRJanuary 6, 2025 · NOC 34633 · Supplement to a New Drug Submission (SNDS)
- SHINGRIXDecember 6, 2024 · NOC 34516 · Supplement to a New Drug Submission (SNDS)
- OJJAARANovember 8, 2024 · NOC 34353 · New Drug Submission (NDS)
- AREXVYNovember 1, 2024 · NOC 34324 · Supplement to a New Drug Submission (SNDS)
- JEMPERLIOctober 29, 2024 · NOC 34306 · Supplement to a New Drug Submission (SNDS)
- JEMPERLIJuly 23, 2024 · NOC 33692 · Supplement to a New Drug Submission (SNDS)
- CLAVULINJune 28, 2024 · NOC 33558 · Supplement to a New Drug Submission (SNDS)
- SHINGRIXJune 10, 2024 · NOC 33422 · Supplement to a New Drug Submission (SNDS)
- JEMPERLIApril 2, 2024 · NOC 32980 · Supplement to a New Drug Submission (SNDS)
- FLOLAN; PH 12 STERILE DILUENT FOR FLOLANMarch 26, 2024 · NOC 32963 · Supplement to a New Drug Submission (SNDS)
- BENLYSTAMarch 15, 2024 · NOC 26254 · Supplement to a New Drug Submission (SNDS)
- LAMICTALMarch 7, 2024 · NOC 32838 · Supplement to a New Drug Submission (SNDS)
- BENLYSTAMarch 6, 2024 · NOC 32834 · Supplement to a New Drug Submission (SNDS)
- ZEJULAJanuary 12, 2024 · NOC 32512 · Supplement to a New Drug Submission (SNDS)
- CLAVULINNovember 29, 2023 · NOC 32208 · Supplement to a New Drug Submission (SNDS)
- NUCALANovember 28, 2023 · NOC 32218 · Supplement to a New Drug Submission (SNDS)
- JEMPERLINovember 15, 2023 · NOC 32102 · Supplement to a New Drug Submission (SNDS)
- BOOSTRIXNovember 9, 2023 · NOC 32078 · Supplement to a New Drug Submission (SNDS)
- BEXSERONovember 9, 2023 · NOC 32079 · Supplement to a New Drug Submission (SNDS)
- BOOSTRIX-POLIONovember 9, 2023 · NOC 32080 · Supplement to a New Drug Submission (SNDS)
- INFANRIX HEXANovember 9, 2023 · NOC 32081 · Supplement to a New Drug Submission (SNDS)
- CERVARIXNovember 9, 2023 · NOC 32082 · Supplement to a New Drug Submission (SNDS)
- ENGERIX-BNovember 9, 2023 · NOC 32083 · Supplement to a New Drug Submission (SNDS)
- SYNFLORIXNovember 9, 2023 · NOC 32084 · Supplement to a New Drug Submission (SNDS)
- TWINRIXNovember 9, 2023 · NOC 32085 · Supplement to a New Drug Submission (SNDS)
- HAVRIXNovember 9, 2023 · NOC 32086 · Supplement to a New Drug Submission (SNDS)
- VENTOLIN RESPIRATOR SOLUTIONSeptember 29, 2023 · NOC 31746 · Supplement to a New Drug Submission (SNDS)
- INCRUSE ELLIPTASeptember 22, 2023 · NOC 31682 · Supplement to a New Drug Submission (SNDS)
- AVODARTSeptember 21, 2023 · NOC 31669 · Supplement to a New Drug Submission (SNDS)
- JALYNSeptember 21, 2023 · NOC 31670 · Supplement to a New Drug Submission (SNDS)
- ARNUITY ELLIPTASeptember 15, 2023 · NOC 31639 · Supplement to a New Drug Submission (SNDS)
- TRELEGY ELLIPTASeptember 13, 2023 · NOC 31609 · Supplement to a New Drug Submission (SNDS)
- CERVARIXSeptember 11, 2023 · NOC 31607 · Supplement to a New Drug Submission (SNDS)
- ZEJULAAugust 17, 2023 · NOC 31431 · Supplement to a New Drug Submission (SNDS)
- AREXVYAugust 4, 2023 · NOC 31366 · New Drug Submission (NDS)
- BENLYSTAMay 23, 2023 · NOC 30807 · Supplement to a New Drug Submission (SNDS)
- CLAVULINApril 24, 2023 · NOC 37397 · Supplement to a New Drug Submission (SNDS)
- ANORO ELLIPTAMarch 9, 2023 · NOC 30293 · Supplement to a New Drug Submission (SNDS)
- MENVEOFebruary 17, 2023 · NOC 30146 · Supplement to a New Drug Submission (SNDS)
- JEMPERLIJanuary 31, 2023 · NOC 30016 · Supplement to a New Drug Submission (SNDS)
- TRELEGY ELLIPTAJanuary 4, 2023 · NOC 29824 · Supplement to a New Drug Submission (SNDS)
- PRIORIX-TETRADecember 7, 2022 · NOC 29652 · Supplement to a New Drug Submission (SNDS)
- PRIORIXDecember 7, 2022 · NOC 29653 · Supplement to a New Drug Submission (SNDS)
- VARILRIXDecember 7, 2022 · NOC 29654 · Supplement to a New Drug Submission (SNDS)
The latest 100 of 684.
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- ZEJULA (niraparib) - Update on the Maintenance Treatment in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in the Second or Later Line SettingFebruary 16, 2023 · Drugs · New safety information
- BOOSTRIX: Syringes may be cracked in affected lot.October 7, 2022 · Biologic or vaccine · Product quality · Type II
- NUCALA PRE-FILLED AUTOINJECTOR(2021-07-09)July 9, 2021 · Drugs · Product safety · Type II
- NUCALA SAFETY SYRINGE(2021-07-09)July 9, 2021 · Drugs · Product safety · Type II
- Menjugate Liquid (2016-03-07)March 17, 2016 · Drugs · Product safety · Type I
- Stieva-A Cream (2015-11-06)November 6, 2015 · Drugs · Product safety · Type III
- Clavulin 400 (2015-04-17)April 20, 2015 · Drugs · Product safety · Type I
- Flolan (2015-03-20)March 24, 2015 · Drugs · Product safety · Type II
- Recall of Paxil Products (2014-04-08)May 1, 2014 · Drugs · Product safety · Type III
- BENLYSTA (belimumab) - Progressive Multifocal Leukoencephalopathy Reported in Patients - For the PublicApril 28, 2014 · Biologic or vaccine · Product safety
- BENLYSTA (belimumab) - Progressive Multifocal Leukoencephalopathy Reported in Patients - For Health ProfessionalsApril 28, 2014 · Biologic or vaccine · Product safety
- Imitrex (2013-11-01)November 21, 2013 · Drugs · Product safety · Type I
- FLOLAN (epoprostenol sodium) - Potential for Glass-related Particles in Sterile Diluent - For Healthcare ProfessionalsApril 24, 2013 · Drugs · Contamination
- FLOLAN (epoprostenol sodium) - Potential for Glass-related Particles in Sterile Diluent - For the PublicApril 24, 2013 · Drugs · Contamination
- Infanrix Hexa - Voluntary Recall of Vaccine Due to Potential Microbiological Contamination - For the PublicNovember 2, 2012 · Specialized products - Drugs - Biologic or vaccine
- Infanrix Hexa - Voluntary Recall of Vaccine Due to Potential Microbiological Contamination - For Health ProfessionalsNovember 2, 2012 · Biologic or vaccine
- Volibris (ambrisentan) - Contraindication in Patients with Idiopathic Pulmonary Fibrosis (IPF) - For the PublicJuly 12, 2012 · Drugs
- Volibris (ambrisentan) - Contraindication in Patients with Idiopathic Pulmonary Fibrosis (IPF) - For Health ProfessionalsJuly 12, 2012 · Drugs
- Benlysta (belimumab) - Association with Hypersensitivity and Infusion Reactions - For Health ProfessionalsMay 8, 2012 · Biologic or vaccine
- BENLYSTA (belimumab) – Association with Hypersensitivity and Infusion Reactions – For the PublicMay 8, 2012 · Drugs · Product safety
- Uremol HC Cream 50 g (tubes) Uremol HC Cream 225 g (jars)May 2, 2011 · Drugs · Type III
- Uremol HC Lotion 150 mLMay 2, 2011 · Drugs · Type III
- AVANDIA, AVANDAMET and AVANDARYL - Important new restrictions on the use of rosiglitazone products due to information on heart-related events - For the PublicNovember 18, 2010 · Drugs
- AVANDIA, AVANDAMET and AVANDARYL - Important New Restrictions on the Use of Rosiglitazone Products Due to Information on Cardiovascular Related Events - For Health ProfessionalsNovember 18, 2010 · Drugs
- Rotarix - Presence of Porcine Circovirus Type 1 (PCV-1) - For Health ProfessionalsJuly 30, 2010 · Biologic or vaccine
- Association of Relenza (zanamivir) Dry Powder for Inhalation with Fatal Outcome when Administered by Nebulization Instead of Inhalation - Notice to HospitalsNovember 5, 2009 · Drugs
- Archived - Cardiac Safety of Avandia (rosiglitazone maleate) - For Health ProfessionalsJune 1, 2007 · Drugs
- Archived - Lamictal (lamotrigine) Tablets - Advisories, Warnings and Recalls for the PublicAugust 8, 2006 · Drugs
- Association of Avandia (rosiglitazone) and Avandamet (rosiglitazone/metformin) with new onset and/or worsening of macular edema - For Health ProfessionalsDecember 21, 2005 · Drugs
- Important safety information on Paxil (paroxetine) and increased risk of cardiac defects following exposure during first trimester of pregnancy - For Health Professionals - GlaxoSmithKline Inc.December 16, 2005 · Drugs
- Archived - Paxil (paroxetine) and Possible Increased Risk of Birth DefectsOctober 7, 2005 · Drugs
- Important Safety Information on Paxil (paroxetine) and Possible Increased Risk of Birth Defects- For Health Professionals- GlaxoSmithKline Inc.September 29, 2005 · Drugs
- Important Safety Information on Serevent – GlaxoSmithKline Inc.September 9, 2005 · Drugs
- Archived - Concomitant Use of Paxil (paroxetine hydrochloride) or Paxil CR (paroxetine hydrochloride controlled release tablets) and pimozide (Orap) Resulting in Arrhythmias (Irregular Heartbeats)July 28, 2005 · Drugs
- Archived - Important Drug Warning - Paxil® - Until further information is available, PAXIL® (paroxetine hydrochloride) should not be used in children and adolescents under 18 years of age - GlaxoSmithKlineJuly 10, 2003 · Health products